Kyn Therapeutics Banks $49M to Advance Cancer Immunometabolism Therapies Post author:Sam Post published:December 13, 2017 Post category:BioPharma Investors were Atlas Venture and OrbiMed. Source: BioSpace You Might Also Like <b>Congress</b> Ignores <b>Trump</b>: the NIH Will Get $2 Billion Boost Despite Proposed Cuts May 1, 2017 Achillion Reports Second Quarter 2017 Financial Results And Proof-Of-Concept With A First-In-Class, Oral Factor D Inhibitor August 8, 2017 Analogic???s Connect Checkpoint CT Scanner To Make Its Debut For The Americas At August 16, 2017
<b>Congress</b> Ignores <b>Trump</b>: the NIH Will Get $2 Billion Boost Despite Proposed Cuts May 1, 2017
Achillion Reports Second Quarter 2017 Financial Results And Proof-Of-Concept With A First-In-Class, Oral Factor D Inhibitor August 8, 2017
